Digest Network Come funziona
Network
/
Società
Ke
Non verificato

Kelonia Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

3 comunicati stampa

Guarda tutti i comunicati
24/11/2025
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Kelonia Therapeutics Announces Late-Breaking Oral Presentation of First-in-Human Data from in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting
Fonte
Kelonia Therapeutics, Inc.
Emittente
Business Wire
1.00
0
19/08/2025
Biotecnologia
Salute
Medicina - Varie
Oncologia
Industria
Kelonia Therapeutics Doses First Patient in Phase 1 inMMyCAR Study Evaluating in vivo CAR T-Cell Therapy for Relapsed and Refractory Multiple Myeloma
Fonte
Kelonia Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/05/2025
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Oncologia
Kelonia Therapeutics to Present iGPS® Preclinical Data at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting
Fonte
Kelonia Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0